(19)
(11) EP 2 928 302 A1

(12)

(43) Date of publication:
14.10.2015 Bulletin 2015/42

(21) Application number: 13861024.1

(22) Date of filing: 04.12.2013
(51) International Patent Classification (IPC): 
A01N 57/00(2006.01)
A61K 31/67(2006.01)
(86) International application number:
PCT/IB2013/060638
(87) International publication number:
WO 2014/087347 (12.06.2014 Gazette 2014/24)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 06.12.2012 IN MM34542012
11.01.2013 BR 102013000830

(71) Applicant: Glenmark Pharmaceuticals Limited
Mumbai 400 099 (IN)

(72) Inventors:
  • DHUPPAD, Ulhas
    Nashik Maharashtra 422101 (IN)
  • CHAUDHARI, Sunil
    Nashik Maharashtra 422101 (IN)
  • RAJURKAR, Suresh
    Nashik Maharashtra 422101 (IN)
  • AGARWAL, Piyush
    Mumbai 400064 Maharashtra (IN)

(74) Representative: HGF Limited 
Belgrave Hall Belgrave Street
Leeds LS2 8DD
Leeds LS2 8DD (GB)

   


(54) FIXED DOSE PHARMACEUTICAL COMPOSITION COMPRISING MOMETASONE AND AZELASTINE